January 25, 2023CorporateTerumo and Siemens Healthineers India collaborate to strengthen cardiac care in India
January 18, 2023CorporateFirst Patient Treated and Enrolled in Terumo Medical Corporation’s Osprey Iliac IDE Clinical TrialTrial aims to assure Terumo’s Misago® RX Self-expanding Peripheral Stent is safe and effective
Investors Japanese Financial Results for the First Half of the Fiscal Year Ending 3/2023 November 10, 2022 IR Library Audio Webcast Stock Quote Prime Market of TSE: Last Trade JPY Change JPY (%) Volume View Chart Top Management Message Shinjiro Sato, President and CEO 5-Year Growth Strategy 2022 - 2026 Terumo Report Sustainability What's New November 14, 2022 Q&A regarding Financial Results for the First Half of FYE 3/2023 November 11, 2022 Audio webcast regarding Financial Results for the First Half of FYE 3/2023 November 10, 2022 Presentation regarding Financial Results for the First Half of FYE 3/2023 August 12, 2022 Q&A regarding Financial Results for the First Quarter of FYE 3/2023 August 10, 2022 Audio webcast regarding Financial Results for FYE 3/2023 View all Business Overview Introduction to the businesses operated by the Terumo Group /business Technology Introduction to Terumo's research and development activities and production system /technology
